Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Detection of Early Lung Cancer Among Military Personnel Study 2 (DECAMP-2): Screening of Patients With Early Stage Lung Cancer or at High Risk for Developing Lung Cancer

NCT02504697 is registered in ClinicalTrials.gov with Boston University as lead sponsor.

NCT NCT02504697
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02504697 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Detection of Early Lung Cancer Among Military Personnel Study 2 (DECAMP-2): Screening of Patients With Early Stage Lung Cancer or at High Risk for Developing Lung Cancer
Lead sponsor
Boston University
Phase
Observational
Overall status
Active, not recruiting
Start date
September 30, 2011
Completion date
December 31, 2027
Enrollment
665 (actual)
Sites
15

Conditions

As the registry lists them; a condition with its own page is linked.

pulmonary disease